Here We Go Again - Now its Mpox
The gain of function terrorists are at it again. Will they ever stop?
On August 14, 2024, the World Health Organization declared Mpox (formerly called Monkeypox) a global health emergency.
A recently released report titled, “Interim Staff Report into Risky MPXV Experiment at the National Institute of Allergy and Infectious Diseases” revealed that the Fauci gang of illegitimate scientists had hidden their work on gain of function research for 9 years.
According to an investigation launched by The House Energy and Commerce Committee, in 2015, Dr. Bernard Moss, a well-known poxvirus researcher at the National Institute of Health’s (NIH)National Institute of Allergy and Infectious Diseases (NIAID), was studying outbreaks of mpox located mostly in the Democratic Republic of Congo.
Moss said he had inserted genes from milder clade II into a clade I virus, He stated that he was next planning to explore whether inserting genes from clade I into clade II viruses made these usually milder viruses more lethal to mice. (the global health emergency is the clade 1 mpox virus)
What makes this even more disturbing is that research members had stated that such gene transfers had never occurred in 2015. There is no documentation either that this research was or wasn’t carried out.
The lack of oversight and evasive tactics of the NIH in the report pose grave questions not just for Mpox, but the entire gain of function research being done on avian influenza, and most likely where the COVID-19 pandemic gain of function done in Wuhan emerged from.
In his recent Substack Dr. Peter McCullough cites a report from the Journal of Autoimmunity titled, “Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak.” In which Dr. McCullough stated that this report indicated that what happened in 2022 almost certainly occurred because of a gain-of-function mutation in one or more genes within the Monkeypox virus. Dr. McCullough goes on to state: “We should keep this in mind as the World Health Organization has declared Monkeypox (clade 1) a “global health emergency” on August 14, 2024. This time the outbreak is largely within the Democratic Republic of Congo, one of the poorest countries in the world with little healthcare, where 96% of ~17,000 cases have been described, but only 10% confirmed by PCR testing. The outbreak is occurring because the virus is spreading in the sex trade workers and miners who commingle.”
What is Mpox?
There are two types of mpox: clade I and clade II.
Clade II was declared a public health emergency in 2022. This form is milder than clade I. Clade 1 was recently declared a world health emergency. The symptoms are more severe, with a mortality rate up to 10%.
At this time, there is very little risk to the general populace.
- Both clades can spread through direct contact with infected wild animals, through close contact (including intimate or sexual contact) with a person with mpox, and through contact with contaminated materials.
- The incubation period is 3-17 days. You can spread mpox to others 1-4 days before symptoms appear.
- Symptoms include rashes that initially look like pimples or blisters, that turn to scabs as they heal and can be found on hands, feet, chest, face or mouth, or near the genitals.
- Other symptoms include fever, chills, swollen lymph nodes, aches, headache sore throat, and nasal congestion.
- Symptoms resolve in about 3 weeks.
- Treatment is with Tecovirimat, which is FDA-approved for the treatment of smallpox only. There are clinical trials ongoing in the CDC’s ongoing expanded access program.
Written By Brooke Lounsbury
